Quest Diagnostics, Inc [DGX] stock prices are up 1.36% to $181.64 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The DGX shares have gain 0.78% over the last week, with a monthly amount glided 8.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on August 25, 2025, when Robert W. Baird downgraded its rating to a Neutral but kept the price target unchanged to $194 for it. Previously, Redburn Atlantic started tracking the stock with Buy rating on April 02, 2025, and set its price target to $195. On March 04, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $185 on the stock. Leerink Partners upgraded its rating to a Outperform and increased its price target to $174 on January 06, 2025. Morgan Stanley upgraded its rating to a Overweight and raised its price target to $172 on December 17, 2024. In a note dated October 23, 2024, Robert W. Baird upgraded an Outperform rating on this stock and boosted its target price from $157 to $182.
The stock price of Quest Diagnostics, Inc [DGX] has been fluctuating between $146.17 and $185.62 over the past year. Currently, Wall Street analysts expect the stock to reach $191.33 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $181.64 at the most recent close of the market. An investor can expect a potential return of 5.33% based on the average DGX price forecast.
Analyzing the DGX fundamentals
The Quest Diagnostics, Inc [NYSE:DGX] reported sales of 10.52B for trailing twelve months, representing a surge of 15.19%. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.14 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.88.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 179.68 points at the first support level, and at 177.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 182.98, and for the 2nd resistance point, it is at 184.31.
Ratios To Look Out For
It’s worth pointing out that Quest Diagnostics, Inc [NYSE:DGX]’s Current Ratio is 1.09. Further, the Quick Ratio stands at 0.99, while the Cash Ratio is 0.16. Considering the valuation of this stock, the price to sales ratio is 1.93, the price to book ratio is 2.81 and price to earnings (TTM) ratio is 21.72.
Transactions by insiders
Recent insider trading involved Plewman Patrick, SVP for Diagnostic Services, that happened on Aug 21 ’25 when 1975.0 shares were sold. SVP for Diagnostic Services, Plewman Patrick completed a deal on Aug 19 ’25 to sell 4532.0 shares. Meanwhile, Officer Plewman Patrick bought 1975.0 shares on Aug 21 ’25.
